AU7582696A - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
AU7582696A
AU7582696A AU75826/96A AU7582696A AU7582696A AU 7582696 A AU7582696 A AU 7582696A AU 75826/96 A AU75826/96 A AU 75826/96A AU 7582696 A AU7582696 A AU 7582696A AU 7582696 A AU7582696 A AU 7582696A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75826/96A
Inventor
Stewart Thomas Leslie
Sandra Therese Antoinette Malkowska
Ronald Brown Miller
Derek Allan Prater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of AU7582696A publication Critical patent/AU7582696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU75826/96A 1995-11-17 1996-11-15 Pharmaceutical formulation Abandoned AU7582696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9523566.9A GB9523566D0 (en) 1995-11-17 1995-11-17 Pharmaceutical formulation
GB9523566 1995-11-17
PCT/GB1996/002824 WO1997018801A1 (en) 1995-11-17 1996-11-15 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
AU7582696A true AU7582696A (en) 1997-06-11

Family

ID=10784062

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75826/96A Abandoned AU7582696A (en) 1995-11-17 1996-11-15 Pharmaceutical formulation

Country Status (3)

Country Link
AU (1) AU7582696A (en)
GB (1) GB9523566D0 (en)
WO (1) WO1997018801A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060029653A1 (en) 1997-01-29 2006-02-09 Cronk Peter J Therapeutic delivery system
DE19807535A1 (en) * 1998-02-21 1999-08-26 Asta Medica Ag Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying
JP5042425B2 (en) * 2000-03-01 2012-10-03 ユーロセルティック ソシエテ アノニム Tramadol for the treatment of functional gastrointestinal diseases
KR100406352B1 (en) * 2001-03-29 2003-11-28 삼성전기주식회사 Antenna and method for manufacture thereof
CN1332664C (en) * 2002-04-26 2007-08-22 中国人民解放军军事医学科学院毒物药物研究所 Snuff
CA2662018A1 (en) 2006-08-30 2008-03-06 David William Smith Method of imparting a mono-axial or multiaxial stiffness to extruded materials and products resulting therefrom
JP2010522135A (en) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド Pharmaceutical composition
EP2240022B1 (en) * 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
CN106413717A (en) * 2014-04-10 2017-02-15 查尔斯顿实验室公司 Pharmaceutical compositions
JP2019507181A (en) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0534628B1 (en) * 1991-09-06 1996-11-20 Mcneilab, Inc. Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone, and their use

Also Published As

Publication number Publication date
GB9523566D0 (en) 1996-01-17
WO1997018801A1 (en) 1997-05-29

Similar Documents

Publication Publication Date Title
AU6995396A (en) Pharmaceutical formulation
AU7572196A (en) Pharmaceutical formulations
AU6216296A (en) Pharmaceutical compositions
AU7499096A (en) Stable freeze-dried pharmaceutical formulation
AU6973396A (en) Pharmaceutical formulation
AU5428096A (en) Oral 2-methyl-thieno-benzodiazepine formulation
EG23826A (en) Pharmaceutical formulations
AU6456996A (en) Polymeric drug formulations
AUPN411195A0 (en) Medicinal composition
AU7590096A (en) Drug composition
AU6904896A (en) Pharmaceutical compounds
AU7265796A (en) Probiotically acting formulation
AU5155096A (en) Pharmaceutical composition
AU5274096A (en) Pharmaceutical compositions
AU7582696A (en) Pharmaceutical formulation
AU5280396A (en) Pharmaceutical microencapsulation
ZA96526B (en) Novel pharmaceutical formulation
AU1475595A (en) Pharmaceutical preparation
AU7546096A (en) Pharmaceutical compounds
AU1195597A (en) Dibenzothiepin derivatives and pharmaceutical compositions
AU5049098A (en) Pharmaceutical formulation
ZA96392B (en) Pharmaceutical formulations
AU6814496A (en) Pharmaceutical composition
AU6443796A (en) Pharmaceutical combination preparation comprising ketoprofen
AU741226C (en) Pharmaceutical composition